Inogen Announces Second Quarter 2019 Financial Results and Updates 2019 Guidance

Go back to Inogen Announces Second Quarter 2019 Financial Results and Updates 2019 Guidance

Inogen (INGN) to Acquire New Aera

August 7, 2019 8:16 AM EDT

Inogen (NASDAQ: INGN) has entered into a definitive agreement to acquire New Aera, Inc. (New Aera), an innovative developer and manufacturer of portable non-invasive ventilators for people suffering from various chronic lung diseases. In connection with the acquisition, Inogen will also separately acquire certain intellectual property assets from an affiliate of New Aera.

New Aeras patented and FDA cleared Tidal Assist® Ventilator (TAV®) system is designed to deliver higher flow and pressure versus traditional oxygen therapy from an approximately 4-ounce pocket-size unit, features a state-of-the-art nasal pillow interface, and is compatible with certain oxygen... More

Inogen (INGN) Misses Q2 EPS by 4c, Lowers FY Guidance

August 7, 2019 8:16 AM EDT

Inogen (NASDAQ: INGN) reported Q2 EPS of $0.45, $0.04 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $101.1 million versus the consensus estimate of $106.87 million.

GUIDANCE:

Inogen sees FY2019 revenue of $370-375 million, versus the consensus of $408.9 million.

Inogen is reducing its full year 2019 total revenue guidance to $370 to $375 million, down from $405 to $415 million, representing growth of 3.3% to 4.7% versus its 2018 full year results. The reduction in full year 2019 total revenue guidance is primarily associated with reduced expectations of the direct-to-consumer sales channel, primarily... More